Limonene and its oxyfunctionalized compounds: Biotransformation by microorganisms and their role as functional bioactive compounds

Food Science and Biotechnology

Volumn 18, Issue 4, 2009, Pages 833-841

  Junior, Mário Roberto Maróstica ^a   Pastore, Gláucia Maria ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anticancer activity; Biological property; Biotransformation; Limonene; Limonene derivatives

Indexed keywords

ANTICANCER ACTIVITIES; BIOLOGICAL PROPERTY; BIOTRANSFORMATION; LIMONENE; LIMONENE DERIVATIVES;

BACTERICIDES; BIOCONVERSION; ESSENTIAL OILS;

FLAVOR COMPOUNDS;

EID: 79954570418     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. U.S. Ag, LLC-100% Nature Friendly Agriculture. Available from: http://www.unitedstatesag.org. Accessed on Sep. 9, 2008.
2. Duetz WA, Bouwmeester H, Beilen JB, Witholt B. Biotransformation of limonene by bacteria, fungi, yeasts, and plants. Appl. Microbiol. Biot. 61: 269-277 (2003)
3. Carvalho CCCR, Fonseca MMR. Biotransformation of terpenes. Biot. Adv. 24: 134-142 (2006)
4. Dhavalikar RS, Bhattacharyya PK. Microbiological transformations of terpenes. VIII. Fermentation of limonene in a soil pseudomonad. Ind. J. Biochem. 3: 144-157 (1966)
5. Dhavalikar RS, Rangachari PN, Bhattacharyya PK. Microbiological transformations of terpenes. IX. Pathways of degradation of limonene in a soil pseudomonad. Ind. J. Biochem. 3: 158-164 (1966)
6. Maróstica-Jr MR, Pastore GM. Production of R-(+)-α-terpineol by the biotransformation of limonene from orange essential oil, using cassava waste water as medium. Food Chem. 101: 345-350 (2007)
7. Braddock RJ, Cadwallader KR. Bioconversion of citrus d-limonene. pp. 142-148. In: Fruit Flavors: Biogenesis, Characterization, and Authentication. Rouseff RL, Leahy MM (eds). ACS Symp. Series No. 596. American Chemical Society, Washington, DC, USA (1995)
8. Maróstica-Jr MR, Pastore GM. Biotransformation of limonene: A review of the main metabolic pathways. Quim. Nova 30: 382-387 (2007)
9. Crowell PL. Prevention and therapy of cancer by dietary monoterpenes J. Nutr. 129: 775S-778S (1999)
10. Van der Werf MJ, Swarts HJ, De Bont JAM. Rhodococcus erythropolis DCL14 contains a novel degradation pathway for limonene. Appl. Environ. Microb. 65: 2092-2102 (1999)
11. Van der Werf, MJ, Keijzer PM, Van der Schaft PH. Xanthobacter sp C20 contains a novel bioconversion pathway for limonene. J. Biotechnol. 84: 133-143 (2000)
12. University of Minnesota. Biocatalysis, biodegradation Database. Available from: http://umbbd.msi.umn.edu/. Accessed on Sep. 9, 2008.
13. Speelmans G, Bijlsma A, Eggink G. Limonene bioconversion to high concentrations of a single and stable product, perillic acid, by a solvent-resistant Pseudomonas putida strain. Appl. Microbiol. Biot. 50: 538-544 (1998)
14. Chatterjee T, Bhattacharyya DK. Biotransformation of limonene by Pseudomonas putida. Appl. Microbiol. Biot. 55: 541-546 (2001)
15. Noma Y, Yamasaki S, Asakawa Y. Biotransformation of limonene and related compounds by Aspergillus cellulosae. Phytochemistry 31: 2725-2727 (1992)
16. Trytek M, Fiedurek J. A novel psychrotrophic fungus, Mortierella minutissima, for d-limonene biotransformation. Biotechnol. Lett. 27: 149-153 (2005)
17. Marostica-Jr MR, Mota NO, Baudet N, Pastore GM. Fungal biotransformation of monoterpenes found in agroiindustrial residues from orange and pulp industries into aroma compounds: Screening using solid phase microextraction. Food Sci. Biotechnol. 16: 37-42 (2007)
18. Abraham WR, Stumpf B, Kieslich K. Microbial transformations of terpenoids with 1-p-menthene skeleton. Appl. Microbiol. Biot. 24: 24-30 (1986)
19. Demyttenaere JCR, van Belleghem K, De Kimpe N. Biotransformation of (R)-(+)- and (S)-(-)-limonene by fungi and the use of solid phase microextraction for screening. Phytochemistry 57: 199-208 (2001)
20. Onken J, Berger RG. Biotransformation of citronellol by the basidiomycete Cystoderma carcharias in a aerated-membrane bioreactor. Appl. Microbiol. Biot. 51: 158-163 (1999)
21. Bowen ER. Potential by-products from microbial transformation of D-limonene. Florida State Horticult. Soc., USA 88: 304-308 (1975)
22. Lupien S, Karp F, Wildung M, Croteau R. Regiospecific cytochrome P450 limonene hydroxylases from mint (mentha) species: cDNA isolation, characterization, and functional expression of (-)-4Slimonene-3-hydroxylase and (-)-4S-limonene-6-hydroxylase. Arch. Biochem. Biophys. 368: 181-192 (1999)
23. Vank T, Valterová I, Vaková R, Vaisar T. Biotransformation of (-)- limonene using Solanum aviculare and Dioscorea deltoidea immobilized plant cells. Biotechnol. Lett. 21: 625-628 (1999)
24. Duetz WA, Fjällman AHM, Ren S, Jourdat C, Witholt B. Biotransformation of D-limonene to (+) trans-carveol by toluenegrown Rhodococcus opacus PWD4 cells. Appl. Environ. Microb. 67: 2829-2832 (2001)
25. Kraidman G, Mukherjee BB, Hill ID. Conversion of D-limonene into an optically active isomer of α-terpineol by a Cladosporium species. Bacteriol. Proc. 69: 63 (1969)
26. Tan Q, Day DF, Cadwallader KR. Bioconversion of (R)-(+)- limonene by P. digitatum (NRRL 1202). Process Biochem. 33: 29-37 (1998)
27. Tan Q, Day DF. Bioconversion of limonene to α-terpineol by immobilized Penicillium digitatum. Appl. Microbiol. Biot. 49: 96-101 (1998)
28. Tan Q, Day DF. Organic co-solvent effects on the bioconversion of (R)-(+)-limonene to (R)-(+)-alpha-terpineol. Process Biochem 33: 755-761 (1998)
29. Adams A, Demyttenaere JCR, De Kimpe N. Biotransformation of (R)-(+)- and (S)-(-)-limonene to α-terpineol by Penicillium digitatum - investigation of the culture conditions. Food Chem. 80: 525-534 (2003)
30. Maróstica-Jr MR, Pastore GM. Biotransformation of citronellol in rose-oxide using cassava wastewater as a medium. Ciênc. Tecnol. Aliment. 26: 609-696 (2006)
31. Bicas JL, Barros FFC, Wagner R, Godoy HT, Pastore GM. Optimization of R-(+)-α-terpineol production by the biotransformation of R-(+)-limonene. J. Ind. Microbiol. Biot. 35: 1061-1070 (2008)
32. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils - A review. Food Chem. Toxicol. 46: 446-475 (2008)
33. Turina AV, Nolan MV, Zygadlo JA, Perillo MA. Natural terpenes: Self-assembly and membrane partitioning. Biophys. Chem. 122: 101-113 (2006)
34. Soylu EM, Soylu S, Kurt S. Antimicrobial activity of the essential oils of various plants against tomato late blight disease agent Phytophthora infestans. Mycopathology 161: 119-128 (2006)
35. Högnadóttir A, Rouseff RL. Identification of aroma active compounds in orange essence oil using gas chromatography-olfactometry and gas chromatography-mass spectrometry. J. Chromatogr. A 998: 201-211 (2003)
36. Selli S, Cabaroglu T, Canbas A. Volatile flavour components of orange juice obtained from the cv. Kozan of Turkey. J. Food Compos. Anal. 17: 789-796 (2004)
37. Sonboli A, Eftekhar F, Yousefzadi M, Kanani MR. Antibacterial activity and chemical composition of the essential oil of Grammosciadium platycarpum Boiss. from Iran. Z. Naturforsch C 60: 30-34 (2005)
38. Mourey A, Canillac N. Anti-Listeria monocytogenes activity of essential oils components of conifers. Food Control 13: 289-292 (2002)
39. Van Sonsbeck HM, Beeftink HH, Tramper J. Two-liquid phase bioreactors. Enzyme Microb. Tech. 15: 722-729 (1993)
40. López-Varela S, González-Gross M, Marcos A. Functional foods and the immune system: A review. Eur. J. Clin. Nutr. 56: S29-S33 (2002)
41. Raphael TJ, Kuttan G. Immunomodulatory activity of naturally occurring monoterpenes carvone, limonene, and perillic acid. Immunopharm. Immunot. 25: 285-294 (2003)
42. Evans DL, Miller DM, Jacobsen KL, Bush PB. Modulation of immune responses in mice by d-limonene. J. Toxicol. Env. Health 20: 51-66 (1987)
43. Hamada M, Uezu K, Matsushita J, Yamamoto S, Kishino Y. Distribution and immune responses resulting from oral administration of d-limonene in rats. J. Nutr. Sci. Vitaminol. 48: 155-160 (2002)
44. Del Toro-Arreola S, Flores-Torales E, Torres-Lozano C, Del Toro- Arreola A, Tostado-Pelayo K, Ramirez-Dueñas MG, Daneri- Navarro A. Effect of d-limonene on immune response in BALB/c mice with lymphoma. Int. Immunopharmacol. 5: 829-838 (2005)
45. Gould MN. Cancer chemoprevention and therapy by monoterpenes. Environ. Health Persp. 105: 977-979 (1997)
46. Watson WH, Cai J, Jones DP. Diet and apoptosis. Annu. Rev. Nutr. 20: 485-505 (2000)
47. Paduch R, KandeferSzerszeñ M, Trytek M, Fiedurek J. Terpenes: Substances useful in human healthcare. Arch. Immunol. Ther. Ex. 55: 315-327 (2007)
48. Samaila D, Toy BJ, Wang RC, Elegbede AJ. Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro. Anticancer Res. 24: 3089-3095 (2004)
49. Da Fonseca CO, Masini M, Futuro D, Caetano R, Gattass CR, Quirico-Santos T. Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: A case report and literature review. Surg. Neurol. 66: 611-615 (2006)
50. Da Fonseca CO, Landeiro JA, Clark SS, Quirico-Santos T, Carvalho MGC, Gattass CR. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol. Surg. Neurol. 65: 2-9 (2006)
51. Da Fonseca CO, Schwartsmann G, Fischer J, Nagel J, Futuro D, Quirico-Santos T, Gattass CR. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. Surg. Neurol. 70: 259-267 (2008)
52. Bailey HH, Attia S, Love RR, Fass T, Tutsch, RCK, Harris L, Jumonville A, Hansen R, Shapiro GR, Stewart JA. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Cancer Chemoth. Pharm. 62: 149-157 (2008)
53. Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 55: 979-983 (1995)
54. Elegbede JA, Floresa R, Wang RC. Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro. Life Sci. 73: 2831-2840 (2003)
55. Clark SS. Perillyl alcohol induces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells. Oncology 70: 13-18 (2006)
56. Clark SS, Zhong L, Filiault D, Perman S, Ren Z, Gould M, Yang X. Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Rafindependent fashion. Clin. Cancer Res. 9: 4494-4504 (2003)
57. Wiseman DA, Werner SR, Crowell PL. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21Cip1 and p27Kip1 in human pancreatic adenocarcinoma cells. J. Pharmacol. Exp. Ther. 320: 1163-1170 (2007)
58. Cox AD. Farnesyltransferase inhibitors: Potential role in the treatment of cancer. Drugs 61: 723-732 (2001)
59. Lebedeva IV, Su ZZ, Vozhilla N, Chatman L, Sarkar D, Dent P, Athar M, Fisher PB. Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis. Mol. Cancer Ther. 7: 2042-2050 (2008)
60. Ariazi EA, Gould MN. Identifying differential gene expression in monoterpene-treated mammary carcinomas using subtractive display. J. Biol. Chem. 271: 29286-29294 (1996)
61. Ahn KJ, Lee CK, Choi EK, Griffin R, Song CW, Park HJ. Cytotoxicity of perillyl alcohol against cancer cells is potentiated by hyperthermia. Int. J. Radiat. Oncol. 57: 813-819 (2003)
62. Holstein SA, Hohl RJ. Monoterpene regulation of Ras and Rasrelated protein expression. J. Lipid Res. 44: 1209-1215 (2003)
63. Loutrari H, Hatziapostolou M, Skouridou V, Papadimitriou E, Roussos C, Kolisis FN, Papapetropoulos A. Perillyl alcohol is an angiogenesis inhibitor. J. Pharmacol. Exp. Ther. 311: 568-575 (2004)